Norden Group’s Idexx Laboratories IDXX Stock Holding History

Norden Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.17M	Sell	3,858 -198	-5%	-$127K	0.21%	98
2025 Q4	$2.74M	Buy	4,056 +199	+5%	+$136K	0.27%	72
2025 Q3	$2.46M	Sell	3,857 -26	-0.7%	-$15.8K	0.25%	79
2025 Q2	$2.08M	Buy	3,883 +3,313	+581%	+$1.58M	0.23%	94
2025 Q1	$239K	Buy	+570	New	+$248K	0.03%	483
2024 Q4	–	Sell	-586	Closed	-$296K	–	541
2024 Q3	$296K	Buy	586 +170	+41%	+$82.6K	0.03%	401
2024 Q2	$203K	Buy	+416	New	+$209K	0.04%	383

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norden Group's IDXX Position: Q1 2026 in Review

Norden Group reduced its Idexx Laboratories (IDXX) stake by 4.9% in Q1 2026, selling an estimated $127K and leaving 3,858 shares worth $2.17M. The position accounts for 0.21% of the portfolio, ranked #98.

Norden Group first reported a position in IDXX in Q2 2024 and has held it in 7 quarters since. The position peaked at $2.74M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Norden Group held 3,858 shares of Idexx Laboratories worth $2.17M as of Q1 2026.
Norden Group sold 198 Idexx Laboratories shares in Q1 2026, an estimated $127K.
Idexx Laboratories made up 0.21% of Norden Group's portfolio in Q1 2026, its #98 holding.
Norden Group first reported a position in Idexx Laboratories in Q2 2024 and has held it in 7 quarters since.
Norden Group's Idexx Laboratories position peaked at $2.74M in Q4 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Norden Group's 13F filing for Q1 2026, filed 15 Apr 2026.